Compare Abeona Therapeutics Inc (ABEO) vs Arista Networks Inc (ANET) Price & Performance

Abeona Therapeutics IncTrade

Arista Networks IncTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Arista Networks Inc — how do they compare? Abeona Therapeutics Inc trades at $7.45 (market cap $421.19M), while Arista Networks Inc trades at $206.03 (market cap $249.53B). The key difference: Arista Networks Inc is far larger — about 592.4× Abeona Therapeutics Inc's market cap, and Arista Networks Inc is trading nearer its 52-week high, Abeona Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

	ABEO	ANET
Market Cap	$421.19M	$249.53B
Sector	Health	Technology
52-Week High	$7.45	$197.85
52-Week Low	$4.17	$116.13
Enterprise Value	$276.10M	$236.19B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abeona Therapeutics Inc

No Aura AI signal available yet.

Arista Networks Inc

Arista Networks (ANET) trades at $191.52, up 1.51% with strong technical momentum and bullish moving average signals. The company demonstrates exceptional fundamentals with 38.4% net margins and consistent earnings beats, though valuation ratios remain elevated. Recent news highlights ANET's leadership in AI networking infrastructure with 40% revenue growth guidance for 2026, positioning it as a key beneficiary of hyperscaler capital expenditure cycles.

Outlook remains positive given robust AI-driven demand and strong analyst consensus, but premium valuation leaves little room for execution missteps. Key risks include competitive pressures and customer concentration with Meta and Microsoft comprising 42% of revenue. The stock offers growth exposure to AI infrastructure but requires monitoring of valuation sustainability.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABEO

View details →

ANET

Arista Networks downgraded to Hold amid high valuation and risks despite strong AI-driven growth prospects.Seeking Alpha · 1 day agoNeutral Arista Networks beats earnings estimates, driven by hyperscaler spending, supporting a strong buy rating.Seeking Alpha · 3 days agoBullish Arista Networks hits record highs on strong AI data center demand but valuation and margin risks prompt cautious outlook.Seeking Alpha · 3 days agoNeutral View details →

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

About Arista Networks Inc

Arista Networks is a software and hardware provider for the networking solutions sector. Operating as one business unit, software, switching, and router products are targeted for high-performance networking applications, while service revenue comes from technical support. Customer markets include data centers, enterprises, service providers, and campuses. The company is headquartered in Santa Clara, California, and generates most of its revenue in the Americas.